Altimmune, Inc.

The current price of ALT is 6.89 USD — it has decreased by 2.13% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Altimmune, Inc. stocks are traded under the ticker ALT.

Altimmune, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

ALT stock is 5.99% volatile and has beta coefficient of 2.32. Check out the list of the most volatile stocks — is Altimmune, Inc. there?

One year price forecast for Altimmune, Inc. has a max estimate of 35.00 USD and a min estimate of 12.00 USD.

ALT earnings for the last quarter are −0.39 USD whereas the estimation was −0.45 USD which accounts for 13.81% surprise. Estimated earnings for the next quarter are −0.46 USD. See more details about Altimmune, Inc. earnings.

Altimmune, Inc. revenue for the last quarter amounts to ‪362.00 K‬ USD despite the estimated figure of 857.00 USD. In the next quarter revenue is expected to reach ‪2.14 K‬ USD.

Yes, you can track Altimmune, Inc. financials in yearly and quarterly reports right on TradingView.

ALT net income for the last quarter is ‪−31.64 M‬ USD, while the quarter before that showed ‪−20.67 M‬ USD of net income which accounts for −53.07% change. Track more Altimmune, Inc. financial stats to get the full picture.

Today Altimmune, Inc. has the market capitalization of ‪488.47 M‬, it has decreased by 7.96% over the last week.

No, ALT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ALT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Altimmune, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ALT reached its all-time high on Mar 14, 2006 with the price of 2724.00 USD, and its all-time low was 1.51 USD and was reached on Nov 19, 2019.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 59.00 employees. See our rating of the largest employees — is Altimmune, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Altimmune, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Altimmune, Inc. stock shows the sell signal. See more of Altimmune, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Altimmune, Inc. future price: according to them, ALT price has a max estimate of 35.00 USD and a min estimate of 12.00 USD. Read a more detailed Altimmune, Inc. forecast: see what analysts think of Altimmune, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Altimmune, Inc. EBITDA is ‪−83.03 M‬ USD, and current EBITDA margin is ‪−19.49 K‬%. See more stats in Altimmune, Inc. financial statements.